Volitionrx limited to present at jefferies global healthcare conference

Henderson, nevada , may 29, 2024 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, announced today that cameron reynolds, president and group chief executive officer, will present and be available for one-to-one meetings at the jefferies global healthcare conference in new york city. presentation details: date: wednesday, june 5, 2024 time: 3.30 pm et (track 3) cameron reynolds, president and group ceo of volition, said: "we are dedicated to improving outcomes for people and animals with life-altering diseases such as sepsis and cancer through earlier detection, disease and treatment monitoring.
VNRX Ratings Summary
VNRX Quant Ranking